The lower molecular weight species may be due to fragmentation (as observed in FTDP-17, as well as AD patients’ brains [36–38]) while the higher molecular weight species with mobility above full-length transgene encoded Tau in Class I and Class II P3 samples were inferred to represent SDS-resistant aggregates. Here, MAPT is linked to Alzheimer disease.